A Subgroup of Patients with a Very Poor Prognosis Diffuse Intrinsic Pontine Glioma Linked to TP53 Alterations By Ogkologos - May 12, 2026 121 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BIOMEDE study Source RELATED ARTICLESMORE FROM AUTHOR How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence Aiming to Improve Cancer Prevention, ESMO Calls for Strong Policy Measures to Fight the Tobacco Epidemic in Feedback on the EU Tobacco Products and... MOST POPULAR Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in... September 27, 2024 EMA Recommends Extension of Therapeutic Indications for Niraparib / Abiraterone Acetate February 20, 2026 Utility of Serial ctDNA in Guiding Anti-EGFR Rechallenge in Metastatic Colorectal... September 7, 2022 Lung cancer screening can’t leave anyone in the UK behind July 27, 2023 Load more HOT NEWS EMA Recommends Extension of Therapeutic Indications for Brentuximab Vedotin Few People with Cancer Undergo Testing for Inherited Gene Mutations EMA Recommends Extension of Indications for Tislelizumab EMA Recommends Granting a Marketing Authorisation for Phesgo (Pertuzumab / Trastuzumab)
